Recent Headlines
Within Pharmaceuticals
Glycosan BioSystems, Inc. is Proud to Announce the Release of Extracel-LG for Stem Cell Applications
Glycosan BioSystems creates a unique extracellular matrix for animal-free stem cell culturing. - September 08, 2007 - Glycosan BioSystems, Inc.
Gamma Medica-Ideas Announces Three Appointments to Its Highly Experienced Multidisciplinary Management Team
Gamma Medica-Ideas Inc. (GM-I), the world leader in developing and delivering digital medical imaging devices for the pre-clinical and clinical markets, announced today three executive appointments to its Multidisciplinary Management Team. Dr. Samir Chowdhury has been named Senior Vice President... - September 07, 2007 - Gamma Medica-Ideas
AnaSpec Introduces New Kinase Peptide Library
AnaSpec, the key supplier of kinase peptide libraries mentioned in the articles, has announced the worldwide commercial availability of its newest kinase peptide library. - September 07, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Fifty-Five New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced fifty-five (55) new peptides for drug discovery research. - September 05, 2007 - AnaSpec, EGT Group
HealthCare Through the Internet
Confidential, Convenient and Affordable Lab Testing - August 30, 2007 - Personalized Lab Services, LLC
BioWest 2007 Organizers Seek the Best and Brightest of the Rocky Mountain Region’s Bioscience Start-Ups for the Venture Showcase Competition
BioWest, The Rocky Mountain Region’s Premier Bioscience Conference and Expo, is again looking for the best bioscience start-ups in the region as candidates for the $10,000 Faegre & Benson Venture Showcase Award. Six companies will be chosen to present at the Showcase in December, which will be judged by a panel of national venture capitalists. Deadline for entry is September 28, 2007. - August 30, 2007 - Colorado BioScience Association
New Labeled Antibodies: Anti-CD-3ε, Anti-CD79α
Leveraging its expertise in both detection reagents and antibodies, AnaSpec has introduced a new series of labeled Anti-CD-3ε and anti-CD79α antibodies. - August 29, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Thirty-Six New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirty-six (36) new peptides for drug discovery research. Protease-Activated Receptor-4; PAR-4 Agonist; amide; human Amyloid Precursor Protein (APP) (667-676); Swedish mutation Colivelin AGA-(C8R)... - August 28, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Industry’s Longest Wavelength Assay Kit for TACE Detection
This week AnaSpec introduced the SensoLyteTM 520 TACE Assay Kit, offering fluorescence detection at the industry’s longest wavelengths. With higher fluorescence quantum yield and longer emission wavelength, this kit shows less autofluorescence interference from test compounds and cellular... - August 28, 2007 - AnaSpec, EGT Group
AnaSpec’s Published References Passes 500
As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 500. - August 26, 2007 - AnaSpec, EGT Group
November Conference Will Show Healthcare Providers How to Partner with Corporations to Provide Wellness Programs
The goal of this conference is to introduce healthcare providers to the $5.8 billion corporate wellness market, show them how to develop and prepare for corporate wellness partnerships and to give insight into the corporation’s needs and goals for providing clinically sound and impactive wellness programs. - August 25, 2007 - Immuno Laboratories
New Help for Smokers Trying to Quit
Paradise Promotions Ltd., a Canadian corporation that manufactures and distributes a government approved herbal-based, smoking cessation aid across Canada, is preparing to launch the medicine into the United States marketplace. - August 25, 2007 - Paradise Promotions Ltd.
Baxa Corporation Ranked by Inc. Magazine as One of the Fastest-Growing Private Companies in the US
Baxa Corporation is now ranked in the list of the top 5,000 fastest-growing private companies in the US. The Inc. 5,000 list is an extension of the magazine’s annual 500 list, recognizing the many businesses that are too big to grow at the pace required to make the well-known Inc. 500 list. - August 25, 2007 - Baxa Corporation
AnaSpec Introduces 10 New Catalog Antibodies
Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added ten (10) new antibodies to its growing collection of catalog antibodies. Anti-MAP1-LC3 beta (NT) - Cat# 29783, 50 µg Host:rabbit polyclonal; Species... - August 25, 2007 - AnaSpec, EGT Group
AnaSpec Introduces CEF Control Peptide Pool
One of the world’s largest providers of catalog peptides, AnaSpec introduced its CEF Control Peptide Pool. Previously available only individually, this group of peptides is now available pooled. The CEF Control Peptide Pool is a group of 32 peptides, 8-12 amino acids in length, with... - August 23, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 28 New Catalog Antibodies
Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added twenty-eight (28) new antibodies to its growing collection of catalog antibodies. - August 22, 2007 - AnaSpec, EGT Group
Samaritan Licenses Tumor Inhibiting Cancer Drugs That Also Distinguish Cancerous Tumors to Improve on Chemotherapy
Samaritan announced that it has entered into an exclusive licensing agreement with Georgetown University for a patent covering the Peripheral Benzodiazepine Receptor (PBR) which has led to Cancer drug candidates with the ability to inhibit cancerous tumors; and an imaging technique that could possibly distinguish cancerous tumors for a more targeted and improved chemotherapy. - August 21, 2007 - Samaritan Pharmaceuticals
Sleep Study Suggests Magnetic Sleep Machine Promotes Deeper Sleep and Reduces Fibromyalgia Pain
Somnogram shows Sleep on Command™ Delta-rhythm magnetic signals help promote slow-wave, Delta-stage sleep throughout the night resulting in remarkable daytime pain relief in subject with fibromyalgia pain. - August 20, 2007 - EarthPulse Tech, LLC
Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
Baxa Corporation announces the future 2008 training schedule for its professional Skills Training, Academics and Resources (STAR) Center for pharmacy and cleanroom skills training. Classes through the remainder of 2007 have been sold out since June. The first class in 2008 will be held January 22-24, with subsequent 2008 program dates: March 18-20, April 22-24 and June 17-19. - August 20, 2007 - Baxa Corporation
AnaSpec Introduces New 2007-2009 Combinatorial Chemistry Catalog
One of the world’s largest providers of unusual amino acids, today AnaSpec announced the release of its 2007-2009 Combinatorial Chemistry catalog. - August 18, 2007 - AnaSpec, EGT Group
Samaritan Licenses Method to Identify Novel Anti-Tumor Drugs to Increase Cancer Compounds in Pipeline
Samaritan Pharmaceuticals has exclusively licensed a patent application entitled "Structure Based Drug Design of Steroid Inhibitors" from Georgetown University. - August 16, 2007 - Samaritan Pharmaceuticals
"Overview of USP 797" Technical Paper by Baxa Corporation’s Mike Hurst Now Accessible on Expert411.com for Media and Professional Reference
The “Overview of USP 797” technical paper, authored by Baxa Corporation’s Mike Hurst, RPh, MBA, is now accessible at Expert411.com for media and professional reference. Most hospital pharmacists simply want to comply with the basic requirements of USP 797 and get on with the business of patient care. This paper is intended to help pharmacies get started in that direction. It also discusses USP 797 from several unique angles not necessarily considered in the initial literature. - August 15, 2007 - Baxa Corporation
To Gift or Not to Gift: Poll Results Reveal Surprising Insight on the Best Gifts for Men
Buying gifts for men can be a tricky situation. While most men prefer gifts they can actually use, the traditional stand-bys (such as clothing, hardware and gadgets) sometimes leave much to be desired. Other gift options recently gaining attention are skincare and grooming products. Modern trends... - August 15, 2007 - MenScience Androceuticals
Is Your Medical Science Liaison (MSL) Program Paying Enough to Attract and Retain the Best MSLs?
According to Medical Science Liaison Institute's independent surveys, more than half of medical science liaisons with less than 2 years of experience report earning a base salary of $100,000 to less than $125,000. - August 14, 2007 - Medical Science Liaison Institute
Synergy Research Group and Promedica International Announce Global Network Alliance for Expansion of Global Clinical Trials Services
On August 2, 2007 Synergy Research Group (SynRG), a Russia based CRO with more than 5-years experience in clinical trials in Russia announced today the establishment of a new Global Network Alliance with Promedica International (PMI), a USA-based CRO. Promedica International (PMI), which... - August 04, 2007 - Synergy Research Group
Aerotrim Wins £3.9M Order from UK MoD
Aerotrim (Warminster) Ltd has secured a £3.9M order for manufacturing insulation lining for MoD tentage used in field operations. - August 04, 2007 - Aerotrim Group
CoreRx™ Celebrates Its First Year of Operations
CoreRx™ celebrates its first year of operations 01 August2007. In their initial year of business CoreRx™ has serviced more than 25 clients, both domestic and abroad. The company has positioned themselves for successful growth strategies over the next few years. Included in... - August 03, 2007 - CoreRx, Inc.
Sarasota’s Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Findings Detailed in The Journal of Clinical Investigation: The Roskamp Institute today released a study defining a mechanism for the development of obesity and the metabolic syndrome, which are the forerunners of type 2 diabetes. The study, led by Roskamp’s Dr. Robert Farese, is detailed in the August issue of The Journal of Clinical Investigation, a highly prestigious medical research journal. - August 01, 2007 - Roskamp Institute
Analytical Results Highlight Efficacy of AnaSpec MOG Peptides
Reporting on results gathered from its antibody and assay kit departments, AnaSpec has released data that supports the efficacy of its MOG(35-55) peptide. Analytical results reported the following: AnaSpec’s mouse/rat MOG(35-55) peptide induced EAE in C57BL/6 mice with 100% incident (10/10). - July 28, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Acetylated and Methylated Lysines
AnaSpec has introduced acetylated, mono-methylated, di-methylated and tri-methylated Lysine for the synthesis of histone peptides. The use of these building blocks, although not limited to making synthetic histone peptides, provides additional tools for researchers to help unravel the... - July 28, 2007 - AnaSpec, EGT Group
Clinical Trials in Russia - 2nd Quarter 2007
On July 25, 2007 Synergy Research Group (SynRG), a Russia-based CRO, presented the current issue of its Orange Paper, a regular analytical report on the market of clinical trials in Russia. The report contains hundreds of figures as well as 11 Tables and 9 Pictures covering various aspects of the... - July 27, 2007 - Synergy Research Group
Travel Kit Sends Men's Grooming Woes Packing
330 million Americans are expected to travel this summer (according to the Travel Industry Association), with men making up a large part of that number. And whether they are businessmen or vacationers, a common trend is for men to cram all grooming items into one inefficient package, often taking... - July 27, 2007 - MenScience Androceuticals
AnaSpec Introduces Fourteen New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced fourteen (14) new peptides for drug discovery research. HIV Nef (68–76) - Cat# 61673 This HIV nef peptide 68 to 76 amino acids was identified in HIV-infected individuals. It is a B7... - July 27, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 12 New Catalog Antibodies
Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added twelve (12) new antibodies to its growing collection of catalog antibodies. The targeted research area for these antibodies is signal transduction and matrix... - July 26, 2007 - AnaSpec, EGT Group
Dry Skin, Cracked Heels, Calluses and Corns Become More Noticeable and Painful During the Summer Months; the Personal Pumi Bar from Teregen Provides Relief
The Personal Pumi Bar gently removes dry Skin, cracked heels, calluses and corns that develop and worsen on feet during the summer months. - July 26, 2007 - Teregen Personal Products
AnaSpec Introduces Ten New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced ten (10) new peptides for drug discovery research. MUC4 - Cat# 61339 This peptide is derived from the tandem repeat of Muc 4 mucin protein. Mucins are highly O-glycosylated proteins which... - July 25, 2007 - AnaSpec, EGT Group
Xcelience Expanding Operations
The Tampa-based contract research organization acquires a brand new building. - July 23, 2007 - Xcelience, LLC
Local Merger Creates Advanced Orthopedics and Sports Medicine Institute
Western Monmouth Orthopedic Associates and New Jersey Orthopedic Associates have merged to form Advanced Orthopedics and Sports Medicine Institute, PC (AOSMI). The seven practicing physicians have a combined 100 years of experience practicing medicine, and are all committed to providing Patient-Centered, Patient-Focused care, positioning AOSMI as a leading provider of orthopedic health care in Central New Jersey and the Monmouth County, NJ area. - July 23, 2007 - Advanced Orthopedics and Sports Medicine Institute, PC
AnaSpec Introduces Eleven New Catalog Peptides
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced eleven (11) new peptides for drug discovery research. - July 22, 2007 - AnaSpec, EGT Group
Supplement Marketer Signs Agreement with Amazon.com, Inc.
Parason Health Products, Inc., makers of ISNA Halal certified dietary supplements, signs agreement with Fortune 500 online e-commerce retailer Amazon.com to sell Parason® brand products. - July 20, 2007 - Parason Health Products, Inc.
AnaSpec Introduces New Selection of Cathelicidin Peptides
Cathelicidins are cationic peptides that have broad-range antimicrobial activity. These peptides belong to the family of anti-microbial peptides which form part of the host’s important innate immunity mechanism. - July 20, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Anti-MMP-1 & Anti-MMP-13 (Hinge) Antibodies
AnaSpec has introduced its newest antibody solutions – anti-MMP-1 (Hinge) and anti-MMP-13 (Hinge) antibodies. Strategically raised against the hinge regions of MMP-1 and MMP-13, the epitopes do not overlap the catalytic domain and will not influence the activity of the MMP ferment in... - July 19, 2007 - AnaSpec, EGT Group
Gamma Medica-Ideas Announces Sale of Flex TriumphTM Multi-Modality Pre-Clinical Imaging System to Université de Rouen
Gamma Medica-Ideas Inc. (GM-I), a leader in providing next-generation medical imaging devices for the pre-clinical and clinical markets, announced today that Université de Rouen in France has placed an order for a dual-modality Flex TriumphTM pre-clinical platform – including its... - July 19, 2007 - Gamma Medica-Ideas
“Premix vs. Custom TPN” Technical Paper Sponsored by Baxa Corporation Now Posted on Expert411.com for Media Access
The “Premix vs. Custom TPN” technical paper, sponsored by Baxa Corporation, is now available at Expert411.com for media and professional access. The paper, which provides a history of nutritional best practice and an examination of the use of premixed solutions for parenteral nutrition, is authored by Louis S. Diorio, RPh, and David L. Thomas, RPh MBA, both with Certified Consultant Pharmacists Healthcare Associates , Inc of Chatham, NJ. - July 18, 2007 - Baxa Corporation
Baxa Corporation Named One of Best Companies to Work for in Colorado
For the second year in a row, Englewood-based Baxa Corporation has been selected as one of Colorado’s best companies to work for; based on results from employee surveys by the Society for Human Resource Management (SHRM). Best Company finalists promote the best employment opportunities in the state – attracting new workers and promoting their retention. - July 16, 2007 - Baxa Corporation
CureHIV Predicts Number of HIV Cases to Skyrocket
Dr. Hershline states that, baring a new preventative, CureHIV now predicts over 700 million worldwide HIV infected humans by the New Year 2018, as this global pandemic emerges. - July 15, 2007 - CureHIV
American Peptide Symposium Poster Describes Synthesis of Hydrocarbon-Stapled Peptides
At the 2007 annual conference of the American Peptide Society, AnaSpec presented a technical poster that described the facile synthesis of a hydrocarbon-stapled peptide. Asymmetric synthesis of (S)-Fmoc-α-(2’-pentenyl)-alanine was successfully accomplished via an Ala-Ni (II)-BPB-complex... - July 14, 2007 - AnaSpec, EGT Group
AnaSpec Presents Late-Breaking In Vivo Imaging Poster at American Peptide Symposium
At the 2007 annual conference of the American Peptide Society, AnaSpec presented a “late-breaking” technical poster that described in vivo imaging using a tissue-specific near infrared fluorescent peptide conjugate. Extracellular matrix proteins that contain the Arg-Gly-Asp (RGD)... - July 13, 2007 - AnaSpec, EGT Group
Cornerstone BioPharma, Inc. and SJ Pharmaceuticals, LLC Sign Co-Promotion Agreement
Cornerstone BioPharma™, the Triangle-based specialty pharmaceutical company currently focused on the development and commercialization of niche prescription medications in the respiratory arena, today announced it has signed a co-promotion agreement with SJ Pharmaceuticals (SJP). This... - July 12, 2007 - Cornerstone BioPharma
Dr. Nasar Appointed Medical Director of CentraState Total Joint Center
Dr. Alan Nasar, a leading orthopedic surgeon at the Advanced Orthopedics and Sports Medicine Institute, PC (AOSMI), is the newly appointed medical director of the Total Joint Center of New Jersey. He draws from his training and experience in orthopedic care and mechanical engineering to offer his patients a variety of joint replacement options that are designed for faster recovery and better outcomes. - July 11, 2007 - Advanced Orthopedics and Sports Medicine Institute, PC